AART: Animal-assisted Resilience Training for Children With Stressful Life Events or Autism Spectrum Disorder

Sponsor
University Hospital, Basel, Switzerland (Other)
Overall Status
Recruiting
CT.gov ID
NCT06025539
Collaborator
(none)
35
1
1
29.7
1.2

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to learn about the effects of an animal-assisted resilience training in children who experienced stressful life events or who have a diagnosis of autism spectrum disorder. The main question it aims to answer is:

• Is an animal-assisted resilience training a feasible approach to increase resilience in children with a history of stressful life events or a diagnosis of autism spectrum disorder?

Participants will take part in 12 training sessions of a standardized resilience training. The training is group-based, takes place outdoors, and includes interactions with different animals. It focuses on self-esteem, self-perception, dealing with emotions, and social competence.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Animal-assisted resilience training
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
35 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Effects of an Animal-assisted Resilience Training for Children With a History of Stressful Life Events or a Diagnosis of Autism Spectrum Disorder: A Pilot Study
Actual Study Start Date :
Aug 10, 2021
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Jan 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Animal-assisted resilience training

12 sessions of group-based, animal-assisted resilience training.

Behavioral: Animal-assisted resilience training
Participants take part in 12 sessions (120 minutes each), each session focuses on a topic that is related to resilience. The intervention takes part outdoors on a farm, and includes interactions with several different animals. The training takes place in small groups, and includes exercises, observations, and discussions.

Outcome Measures

Primary Outcome Measures

  1. Questionnaire on resources in childhood and adolescence [18 weeks]

    Pre-to-post assessment changes in resilience

Secondary Outcome Measures

  1. Questionnaire to assess emotion regulation in children and adolescents [18 weeks]

    Pre-to-post assessment changes in emotion regulation

  2. Number of attendend sessions [12 weeks]

    Number of attended sessions over the course of the training

  3. Feeling secure and motivation to participate as measured on a 0-10 scale [12 weeks]

    Motivation and feeling secure as measured at the beginning and end of each session

  4. Intervention satisfaction as assessed in semi-structured interview [18 weeks (follow-up)]

    Satisfaction with program content and structure, as measured by qualitative interview

  5. Strengths and Difficulties Questionnaire (SDQ) [18 weeks]

    Pre-to-post assessment changes in peer-relationship problems and prosocial behavior measures

Eligibility Criteria

Criteria

Ages Eligible for Study:
2 Years to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age between 2 and 4 years (toddler group) or 8 and 12 years (children group)

  • History of at least one stressful life event experience OR diagnosis of autism spectrum disorder

  • Basic knowledge of either German or English of parents and child to follow the instructions during the training sessions and completion of interviews.

Exclusion Criteria:
  • Medical contraindications for contact with animals, such as allergies or phobia

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Basel Basel Switzerland 4055

Sponsors and Collaborators

  • University Hospital, Basel, Switzerland

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier:
NCT06025539
Other Study ID Numbers:
  • Resilience training
First Posted:
Sep 6, 2023
Last Update Posted:
Sep 6, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 6, 2023